Buy or sell XinThera stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

XinThera Stock

XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.

About XinThera Stock

XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.

Funding History

August 2021$50.0M

Management

Board Member

Carl L. Gordon

Co-founder and Senior Vice President

Gene Hung

Board Member

Michael Rome

Co-Founder and Chairman

Stephen Kaldor

Board Member

Jim Tananbaum

President & CSO

Qing Dong

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 300K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo